Order Article Reprints

Suleman M, Arbab H, Yassine HM, Sayaf AM, Ilahi U, Alissa M, Alghamdi A, Alghamdi SA, Crovella S, Shaito AA. Repurposing Nirmatrelvir for Hepatocellular Carcinoma: Network Pharmacology and Molecular Dynamics Simulations Identify HDAC3 as a Key Molecular Target. Pharmaceuticals. 2025; 18(8):1144. https://doi.org/10.3390/ph18081144

Suleman, Muhammad, Hira Arbab, Hadi M. Yassine, Abrar Mohammad Sayaf, Usama Ilahi, Mohammed Alissa, Abdullah Alghamdi, Suad A. Alghamdi, Sergio Crovella, and Abdullah A. Shaito. 2025. "Repurposing Nirmatrelvir for Hepatocellular Carcinoma: Network Pharmacology and Molecular Dynamics Simulations Identify HDAC3 as a Key Molecular Target" Pharmaceuticals 18, no. 8: 1144. https://doi.org/10.3390/ph18081144

Suleman, M., Arbab, H., Yassine, H. M., Sayaf, A. M., Ilahi, U., Alissa, M., Alghamdi, A., Alghamdi, S. A., Crovella, S., & Shaito, A. A. (2025). Repurposing Nirmatrelvir for Hepatocellular Carcinoma: Network Pharmacology and Molecular Dynamics Simulations Identify HDAC3 as a Key Molecular Target. Pharmaceuticals, 18(8), 1144. https://doi.org/10.3390/ph18081144